National Institute of Dental & Craniofacial Research; Notice of Partially Closed Meeting, 66731-66732 [2024-18422]
Download as PDF
<![CDATA[
lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 89, No. 159 / Friday, August 16, 2024 / Notices
and Uses Thereof’’ [HHS Reference No.
E–070–2012–0–US–04];
5. Germany Patent No.
602013016154.2, filed October 30, 2014,
entitled ‘‘Derivatives Of
Docosahexaenoylamide and Uses
Thereof’’ [HHS Reference No. E–070–
2012–0–DE–05];
6. France Patent No. 2847178, filed
October 30, 2014, entitled ‘‘Derivatives
Of Docosahexaenoylamide and Uses
Thereof’’ [HHS Reference No. E–070–
2012–0–FR–06];
7. Great Britain Patent No. 2847178,
filed October 30, 2014, entitled
‘‘Derivatives Of Docosahexaenoylamide
and Uses Thereof’’ [HHS Reference No.
E–070–2012–0–GB–07].
The patent rights in these inventions
have been assigned and/or exclusively
licensed to the government of the
United States of America.
The prospective exclusive license
territory may be worldwide, and the
field of use may be limited to the
following:
‘‘Use of a G-protein-coupled receptor
110 (‘‘GPR110’’) agonist named
dimethyl synaptamide (‘‘DMS’’) (also
known as Compound NCGC00248435;
(4Z,7Z,10Z,13Z,16Z,19Z)-N-(2-hydroxy2-methylpropyl) docosa-4,7,10,13,16,19hexaenamide; or ‘‘A8’’) to treat multiple
sclerosis (‘‘MS’’), chronic inflammatory
demyelinating polyradiculoneuropathy
(‘‘CIDP’’), psoriasis, inflammatory bowel
disease (‘‘IBD’’), Crohn’s disease,
ulcerative colitis (‘‘UC’’), sclerosing
cholangitis, ankylosing spondylitis,
rheumatoid arthritis (‘‘RA’’), psoriatic
arthritis, systemic lupus erythematosus
(‘‘SLE’’), lupus nephritis, sarcoidosis,
and Behcet’s disease.’’
This notice is made in accordance
with 35 U.S.C. 209 and 37 CFR part 404.
The prospective exclusive license will
be royalty bearing, and the prospective
exclusive license may be granted unless
within fifteen (15) days from the date of
this published notice, the NHLBI Office
of Technology Transfer And
Development receives written evidence
and argument that establishes that the
grant of the license would not be
consistent with the requirements of 35
U.S.C. 209 and 37 CFR part 404.
In response to this Notice, the public
may file comments or objections.
Comments and objections, other than
those in the form of a license
application, will not be treated
confidentially, and may be made
publicly available.
License applications submitted in
response to this Notice will be
presumed to contain business
confidential information and any release
of information in these license
applications will be made only as
VerDate Sep<11>2014
17:33 Aug 15, 2024
Jkt 262001
66731
required and upon a request under the
Freedom of Information Act, 5 U.S.C.
552.
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Bruce D. Goldstein,
Director, Office of Technology Transfer and
Development, National Heart, Lung, and
Blood Institute.
Dated: August 13, 2024
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–18381 Filed 8–15–24; 8:45 am]
[FR Doc. 2024–18412 Filed 8–15–24; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
National Institute of Dental &
Craniofacial Research; Notice of
Partially Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Respiratory Sciences.
Date: September 9, 2024.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Michael L. Bloom, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6187,
MSC 7804, Bethesda, MD 20892, 301–451–
0132, bloomm2@mail.nih.gov.
Name of Committee: Risk, Prevention and
Health Behavior Integrated Review Group;
Biobehavioral Medicine and Health
Outcomes Study Section.
Date: September 19–20, 2024.
Time: 9:30 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Mark A. Vosvick, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3110,
Bethesda, MD 20892, (301) 402–4128,
mark.vosvick@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory Dental
and Craniofacial Research Council.
The meeting will be held as a virtual
meeting and is partially open to the
public as indicated below. Individuals
who plan to view the virtual meeting
and need special assistance to view the
meeting, such as sign language
interpretation or other reasonable
accommodations, should notify the
Contact Person listed below in advance
of the meeting. The open session will be
videocast and can be accessed from the
NIH Videocasting website (https://
videocast.nih.gov/). Registration is not
required to access the videocast.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National
Advisory Dental and Craniofacial
Research Council.
Date: September 11, 2024.
Open: 10:00 a.m. to 3:15 p.m.
Agenda: Report of the Director,
NIDCR and concept clearances.
Place: National Institute of Dental &
Craniofacial Research, 6701 Democracy
Boulevard, Bethesda, MD 20892,
(Virtual Meeting).
Closed: 3:30 p.m. to 4:15 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Dental &
Craniofacial Research, 6701 Democracy
Boulevard, Bethesda, MD 20892,
(Virtual Meeting).
E:\FR\FM\16AUN1.SGM
16AUN1
66732
Federal Register / Vol. 89, No. 159 / Friday, August 16, 2024 / Notices
Contact Person: Lynn M King, Ph.D.,
Executive Secretary, Division of
Extramural Activities, National Institute
of Dental & Craniofacial Research,
National Institutes of Health, 6701
Democracy Blvd., Bethesda, MD 20892–
4878, (301) 594–5006, Lynn.King@
nih.gov.
Any interested person may file
written comments with the committee
by forwarding the statement to the
Contact Person listed on this notice. The
statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
www.nidcr.nih.gov/about-us/advisorycommittees/advisory-council, where an
agenda and any additional information
for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance
Program No. 93.121, Oral Diseases and
Disorders Research, National Institutes of
Health, HHS)
Dated: August 13, 2024.
Bruce A. George,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–18422 Filed 8–15–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
U.S. Citizenship and Immigration
Services
[OMB Control Number 1615–0020]
Agency Information Collection
Activities; Revision of a Currently
Approved Collection: Petition for
Amerasian, Widow(er), or Special
Immigrant
U.S. Citizenship and
Immigration Services, Department of
Homeland Security.
ACTION: 60-Day notice.
AGENCY:
The Department of Homeland
Security (DHS), U.S. Citizenship and
Immigration Services (USCIS) invites
the general public and other Federal
agencies to comment upon this
proposed revision of a currently
approved collection of information. In
accordance with the Paperwork
Reduction Act (PRA) of 1995, the
information collection notice is
published in the Federal Register to
obtain comments regarding the nature of
the information collection, the
categories of respondents, the estimated
burden (i.e. the time, effort, and
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
17:33 Aug 15, 2024
Jkt 262001
resources used by the respondents to
respond), the estimated cost to the
respondent, and the actual information
collection instruments.
DATES: Comments are encouraged and
will be accepted for 60 days until
October 15, 2024.
ADDRESSES: All submissions received
must include the OMB Control Number
1615–0020 in the body of the letter, the
agency name and Docket ID USCIS–
2007–0024. Submit comments via the
Federal eRulemaking Portal website at
https://www.regulations.gov under eDocket ID number USCIS–2007–0024.
FOR FURTHER INFORMATION CONTACT:
USCIS, Office of Policy and Strategy,
Regulatory Coordination Division,
Samantha Deshommes, Chief, telephone
number (240) 721–3000 (This is not a
toll-free number. Comments are not
accepted via telephone message). Please
note contact information provided here
is solely for questions regarding this
notice. It is not for individual case
status inquiries. Applicants seeking
information about the status of their
individual cases can check Case Status
Online, available at the USCIS website
at https://www.uscis.gov, or call the
USCIS Contact Center at 800–375–5283
(TTY 800–767–1833).
SUPPLEMENTARY INFORMATION:
Comments
You may access the information
collection instrument with instructions
or additional information by visiting the
Federal eRulemaking Portal site at:
https://www.regulations.gov and
entering USCIS–2007–0024 in the
search box. Comments must be
submitted in English, or an English
translation must be provided. All
submissions will be posted, without
change, to the Federal eRulemaking
Portal at https://www.regulations.gov,
and will include any personal
information you provide. Therefore,
submitting this information makes it
public. You may wish to consider
limiting the amount of personal
information that you provide in any
voluntary submission you make to DHS.
DHS may withhold information
provided in comments from public
viewing that it determines may impact
the privacy of an individual or is
offensive. For additional information,
please read the Privacy Act notice that
is available via the link in the footer of
https://www.regulations.gov.
Written comments and suggestions
from the public and affected agencies
should address one or more of the
following four points:
(1) Evaluate whether the proposed
collection of information is necessary
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(2) Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(3) Enhance the quality, utility, and
clarity of the information to be
collected; and
(4) Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses.
Overview of This Information
Collection
(1) Type of Information Collection:
Revision of a Currently Approved
Collection.
(2) Title of the Form/Collection:
Petition for Amerasian, Widow(er), or
Special Immigrant.
(3) Agency form number, if any, and
the applicable component of the DHS
sponsoring the collection: Form I–360;
USCIS.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract: Primary: Individuals or
households. Form I–360 may be used by
an Amerasian; a widow or widower; a
battered or abused spouse or child of a
U.S. citizen or lawful permanent
resident; a battered or abused parent of
a U.S. citizen son or daughter; or a
special immigrant (religious worker,
Panama Canal company employee,
Canal Zone government employee, U.S.
government employee in the Canal
Zone; physician, international
organization employee or family
member, juvenile court dependent;
armed forces member); Afghan or Iraqi
national who supported the U.S. Armed
Forces as a translator; Iraqi national who
worked for the or on behalf of the U.S.
Government in Iraq; or Afghan national
who worked for or on behalf of the U.S.
Government or the International
Security Assistance Force [ISAF] in
Afghanistan who intend to establish
their eligibility to immigrate to the
United States. The data collected on this
form is reviewed by USCIS to determine
if the petitioner may be qualified to
obtain the benefit. The data collected on
this form will also be used to issue an
employment authorization document
upon approval of the petition for
battered or abused spouses, children,
and parents, if requested.
E:\FR\FM\16AUN1.SGM
16AUN1
]]>Agencies
[Federal Register Volume 89, Number 159 (Friday, August 16, 2024)]
[Notices]
[Pages 66731-66732]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-18422]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Dental & Craniofacial Research; Notice of
Partially Closed Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Advisory
Dental and Craniofacial Research Council.
The meeting will be held as a virtual meeting and is partially open
to the public as indicated below. Individuals who plan to view the
virtual meeting and need special assistance to view the meeting, such
as sign language interpretation or other reasonable accommodations,
should notify the Contact Person listed below in advance of the
meeting. The open session will be videocast and can be accessed from
the NIH Videocasting website (https://videocast.nih.gov/). Registration
is not required to access the videocast.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Dental and Craniofacial
Research Council.
Date: September 11, 2024.
Open: 10:00 a.m. to 3:15 p.m.
Agenda: Report of the Director, NIDCR and concept clearances.
Place: National Institute of Dental & Craniofacial Research, 6701
Democracy Boulevard, Bethesda, MD 20892, (Virtual Meeting).
Closed: 3:30 p.m. to 4:15 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Dental & Craniofacial Research, 6701
Democracy Boulevard, Bethesda, MD 20892, (Virtual Meeting).
[[Page 66732]]
Contact Person: Lynn M King, Ph.D., Executive Secretary, Division
of Extramural Activities, National Institute of Dental & Craniofacial
Research, National Institutes of Health, 6701 Democracy Blvd.,
Bethesda, MD 20892-4878, (301) 594-5006, [email protected].
Any interested person may file written comments with the committee
by forwarding the statement to the Contact Person listed on this
notice. The statement should include the name, address, telephone
number and when applicable, the business or professional affiliation of
the interested person.
Information is also available on the Institute's/Center's home
page: https://www.nidcr.nih.gov/about-us/advisory-committees/advisory-council, where an agenda and any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance Program No. 93.121, Oral
Diseases and Disorders Research, National Institutes of Health, HHS)
Dated: August 13, 2024.
Bruce A. George,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-18422 Filed 8-15-24; 8:45 am]
BILLING CODE 4140-01-P
